Stivarga (Bayer HealthCare Pharmaceuticals Inc.)
Welcome to the PulseAid listing for the Stivarga drug offered from Bayer HealthCare Pharmaceuticals Inc.. This Kinase Inhibitor [EPC],Protein Kinase Inhibitors [MoA],Cytochrome P450 2C9 Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Bayer HealthCare Pharmaceuticals Inc. |
| NON-PROPRIETARY NAME: | regorafenib |
| SUBSTANCE NAME: | REGORAFENIB MONOHYDRATE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Kinase Inhibitor [EPC],Protein Kinase Inhibitors [MoA],Cytochrome P450 2C9 Inhibitors [MoA] |
| ROUTE: | ORAL |
| DOSAGE FORM: | TABLET, FILM COATED |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2012-09-27 |
| END MARKETING DATE: | 0000-00-00 |
Stivarga HUMAN PRESCRIPTION DRUG Details:
| Item Description | Stivarga from Bayer HealthCare Pharmaceuticals Inc. |
| LABELER NAME: | Bayer HealthCare Pharmaceuticals Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 40(mg/1) |
| START MARKETING DATE: | 2012-09-27 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 50419-171_a4e10546-4306-44f4-b670-e203d495e794 |
| PRODUCT NDC: | 50419-171 |
| APPLICATION NUMBER: | NDA203085 |
Other REGORAFENIB MONOHYDRATE Pharmaceutical Manufacturers / Labelers:
